Theraclion SA (TCLIF)

Market Cap	44.39M +475.0%
Revenue (ttm)	765.53K +179.3%
Net Income	-6.68M
EPS	-0.11
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	500
Average Volume	2,367
Open	0.5320
Previous Close	n/a
Day's Range	0.5320 - 0.5320
52-Week Range	0.0002 - 0.5900
Beta	0.18
RSI	n/a
Earnings Date	Apr 16, 2026

About Theraclion

Theraclion SA provides therapeutic ultrasound equipment. It offers SONOVEIN, a robotic solution for the non-invasive echotherapy treatment of varicose veins; ECHOPULSE, a robotic and non-invasive solution for the echotherapy treatment of thyroid nodules and breast fibroadenoma; and EPack, a disposable that is installed on the device before treatment to protect the patient’s skin and optimize image quality. The company was incorporated in 2004 and is headquartered in Malakoff, France.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2004
• Employees: 31
• Stock Exchange: OTCMKTS
• Ticker Symbol: TCLIF

Financial Performance

In 2025, Theraclion's revenue was 2.32 million, an increase of 179.33% compared to the previous year's 830,209. Losses were -5.69 million, -1.17% less than in 2024.

Financial numbers in EUR